Financhill
Sell
24

SWBI Quote, Financials, Valuation and Earnings

Last price:
$9.52
Seasonality move :
13.16%
Day range:
$9.41 - $9.64
52-week range:
$9.17 - $17.99
Dividend yield:
5.47%
P/E ratio:
14.63x
P/S ratio:
0.87x
P/B ratio:
1.15x
Volume:
726K
Avg. volume:
543.9K
1-year change:
-47.02%
Market cap:
$418.5M
Revenue:
$535.8M
EPS (TTM):
$0.65

Earnings Data

Next earnings date for SWBI
Jun 20
2025
Most recent earnings per share
$0.04
Beat by $0.02
(Mar 6/2025)
Consensus Estimate
$0.02
(Mar 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SWBI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/20/2025 Q2 $152.4M -- -- $0.23 --
03/06/2025 Q1 $119.5M $115.9M $0.04 $0.02 $0.02
12/05/2024 Q4 $133.5M $129.7M $0.09 $0.17 -$0.08
09/05/2024 Q3 $102.5M $88.3M -$0.05 -$0.02 -$0.03
06/20/2024 Q2 $156.8M $159.1M $0.57 $0.36 $0.22
03/07/2024 Q1 $133.5M $137.5M $0.17 $0.11 $0.07
12/07/2023 Q4 $123.9M $125M $0.05 $0.18 -$0.13
09/07/2023 Q3 $100.9M $114.2M $0.07 $0.11 -$0.04
06/22/2023 Q2 $138.4M $144.8M $0.28 $0.29 -$0.01
03/09/2023 Q1 $125.4M $129M $0.24 $0.23 $0.01
12/06/2022 Q4 -- $121M $0.21 -- --
09/08/2022 Q3 -- $84.4M $0.07 -- --
06/23/2022 Q2 -- $181.3M $0.79 -- --
03/03/2022 Q1 -- $177.7M $0.65 -- --
12/02/2021 Q4 -- $230.5M $1.05 -- --
09/01/2021 Q3 -- $274.6M $1.57 -- --
06/17/2021 Q2 -- $322.9M $1.70 -- --
03/04/2021 Q1 -- $257.6M $1.12 -- --
12/03/2020 Q4 -- $248.7M $0.92 -- --
09/03/2020 Q3 -- $229.9M $0.86 -- --
06/18/2020 Q2 -- $193M -$1.20 -- --
03/05/2020 Q1 -- $127.4M $0.10 -- --
12/05/2019 Q4 -- $113.7M $0.02 -- --
08/29/2019 Q3 -- $123.7M -$0.04 -- --
06/19/2019 Q2 -- $18.8M $0.18 -- --
03/07/2019 Q1 -- $162M -$0.10 -- --
12/06/2018 Q4 -- $161.7M $0.12 -- --
08/30/2018 Q3 -- $138.8M $0.14 -- --
06/20/2018 Q2 -- $172M $0.14 -- --
03/01/2018 Q1 -- $157.4M $0.21 -- --
12/07/2017 Q4 -- $148.4M $0.06 -- --
09/07/2017 Q3 -- $129M -$0.04 -- --
06/29/2017 Q2 -- $229.2M $0.50 -- --
03/02/2017 Q1 -- $233.5M $0.57 -- --
12/01/2016 Q4 -- $233.5M $0.57 -- --
09/01/2016 Q3 -- $207M $0.62 -- --
06/16/2016 Q2 -- $221.1M $0.63 -- --
03/03/2016 Q1 -- $210.8M $0.56 -- --
12/08/2015 Q4 -- $143.2M $0.22 -- --
08/27/2015 Q3 -- $147.8M $0.26 -- --
06/18/2015 Q2 -- $181M $0.40 -- --

Smith & Wesson Brands Earnings Questions

  • How Much did Smith & Wesson Brands Generate in Revenue Last Quarter?

    Smith & Wesson Brands reported $115.9M worth of top line sales in its most recent quarter.

  • Did Smith & Wesson Brands Beat Earnings Last Quarter?

    Smith & Wesson Brands announced earnings per share of $0.04 which represents a beat of analyst forecast a $0.02 per share.

  • Is Smith & Wesson Brands Profitable?

    Smith & Wesson Brands reported $27.9M that represents $0.63 per share over the last quarter.

  • What is the Analyst Consensus for Smith & Wesson Brands EPS Next Year?

    Smith & Wesson Brands's earnings are forecast to decrease from $0.86 per share to $0.33 per share next year representing a decrease of -61.63%.

  • When is Smith & Wesson Brands's Earnings Date?

    Smith & Wesson Brands's next earnings date is June 20, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock